The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System
To access this article, please choose from the options below
See accompanying Articles on pages 43 and 59.
PII: S0002-9394(09)00284-0
doi:10.1016/j.ajo.2009.04.010
© 2009 Elsevier Inc. All rights reserved.
Refers to article:
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study , 20 April 2009
- Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study , 20 April 2009
